TrialScientific reports2019

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients.

Aglaia Schiza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.